The analysis of pharmacovigilance for a drug, utilizing postmarketing safety databases like the FAERS, plays a crucial role in the ongoing management of risks by detecting safety signals that may not have been identified during the drugs clinical development phase [Reference Anand, Ensor, Trachtenberg and Bernicker10, Reference Jedlowski, Jedlowski and Fazel14, Reference Egeberg and Thyssen32Reference Yu, Krantz, Phillips and Stone35]
Ro Launches GLP-1 Insurance Coverage Checker Social Sharing 08.13.2024 Understanding your insurance coverage and out-of-pocket costs before youre treated should be table stakes in healthcare
Assess and document the patients sensory and motor function, including paresthesias, burning sensations, and numbness in the lower extremities, to establish a baseline and monitor the progression of peripheral neuropathy
Impact of glucagon-like peptide-1 receptor agonists on adiponectin concentrations: A meta-analysis of randomized controlled trials
